Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-26
SponsorMilton S. Hershey Medical Center
About this trial
The goal of this study is to develop and refine an artificial intelligence (AI)-powered Exposure Therapy for Eating Disorders chatbot web-app that effectively engages adolescents and young adults and decreases anxiety about weight gain. Participants will use the web-app as a supplemental therapeutic tool during their first six weeks of treatment in a Partial Hospitalization Program. Participants will complete assessments every two weeks, including: (1) semi-structured interviews about their experience with the chatbot web-app; (2) implementation outcome measures (e.g., feasibility, usability, acceptability); and (3) anxiety about weight gain.
Eligibility criteria
Qualifiers
Age is between or equal to 12-26 years
Admitted to the Penn State Health Eating Disorder Partial Hospital Program (PHP) or Intensive Outpatient Program (IOP)
Have a personal smartphone
Have a diagnosis of anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), or other specified feeding or eating disorder (OSFED)
Disqualifiers
Diagnosis of avoidant/restrictive food intake disorder (ARFID)
Have acute suicidality
Diagnosis of an intellectual disability
Trial design
Treatments tested in this trial
- "Exp-ED" Digital Exposure-Therapy Chatbot app
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov